SCHEMBL31268903

SCHEMBL31268903

Cc1ccnc(Cn2c(-c3ccc(OC[C@H]4CCO4)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ PIK3CD O00329 6/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ LRRK2 Q5S007 3/20 0.32
▸ GRM5 P41594 2/20 0.32
▸ PIK3R1 P27986 1/20 0.31
▸ PRKAB2 O43741 1/20 0.30
▸ PRKAG1 P54619 1/20 0.30
▸ PRKAA2 P54646 1/20 0.30
▸ PRKAA1 Q13131 1/20 0.30
▸ PRKAG3 Q9UGI9 1/20 0.30
▸ PRKAG2 Q9UGJ0 1/20 0.30
▸ PRKAB1 Q9Y478 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269086 0.90 PDE2A (0.33) KCNH2SCN5ASCN9APIK3CDGRM5
SCHEMBL31269243 0.89 LMNA (0.38) KCNH2SCN5ASCN9APIK3CDLRRK2
SCHEMBL31269362 0.89 S1PR1 (0.34) KCNH2SCN5ASCN9APIK3CD
SCHEMBL31268854 0.88 CHRNA3 (0.35) KCNH2SCN5ASCN9APIK3CDPRKAB2
SCHEMBL31268874 0.87 KDM4E (0.32) KCNH2SCN5ASCN9APIK3CD
SCHEMBL31269061 0.87 MET (0.33) KCNH2SCN5ASCN9APIK3CDLRRK2
SCHEMBL30983456 0.87 PIK3CD (0.35) KCNH2SCN5ASCN9APIK3CD
SCHEMBL30984004 0.87 KCNH2 (0.32) KCNH2SCN5ASCN9APIK3CD
SCHEMBL31269380 0.87 PDE2A (0.38) KCNH2SCN5ASCN9APIK3CD
SCHEMBL31268950 0.87 KCNH2 (0.32) KCNH2SCN5ASCN9APIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback